‘India requires sound policies to compete in rapidly-growing global nutraceutical, Ayurveda markets’

‘The farming community was skeptical about the cultivation of non-traditional crops due to a lack of clarity on market opportunities’

Updated - January 08, 2023 01:18 pm IST

Published - January 07, 2023 10:10 pm IST - Bengaluru

There is an urgent need for India to formulate sound policies and create the necessary infrastructure to meet the global statutory requirements for nutraceutical and ayurvedic products, stated Dr. Muhammed Majeed, Chairman & Founder, Sami-Sabinsa Group, a health-science player.

“A rapidly expanding global nutraceutical and Ayurveda market requires India to make concerted policy, regulatory, and marketing efforts to ensure sustained global acceptance of our AYUSH and nutraceutical products,’‘ he told The Hindu.

This included establishing pharmacopeial standards, robust quality control, setting up regional testing laboratories, stronger enforcement of AYUSH drug regulations, and further empowering the Export Promotion Council to promote plant extracts and nutraceuticals, he added.

According to him, the planned cultivation of medicinal plants is still at a nascent stage in the country and therefore the AYUSH Industry still depended on the wild for its supplies. Also, the farming community was skeptical about the cultivation of non-traditional crops due to a lack of clarity on market opportunities, he observed.

Dr. Majeed further said, “The National Medicinal Plants Board (NMPB) should aggressively encourage the farming community to take up the cultivation of medicinal plants by providing incentive grants and marketing support.’‘

Such an effort would not only help marginalised farmers, but also ensure high-quality raw materials for the industry, lowers raw material costs, and boosts the competitiveness of Indian Ayurvedic and nutraceutical exports, he believed.

He further said, in markets such as the U.S., Europe, Japan, Australia, etc. where preventive health care was gaining prominence and focus on Ayurveda and neutraceutical was on the rise. “But, regulations are very stringent in global markets to ensure quality and safety standards. India needs to immediately focus on policy and regulatory issues,’‘ Dr. Majeed concluded.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.